ArticleFrontiers in immunology2021

Chimeric Antigens Receptor T Cell Therapy Improve the Prognosis of Pediatric Acute Lymphoblastic Leukemia With Persistent/Recurrent Minimal Residual Disease in First Complete Remission.

Guan-Hua Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.